AFFINITY INVESTMENT ADVISORS, LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 252 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
AFFINITY INVESTMENT ADVISORS, LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$488,559
-9.5%
50,7330.0%0.32%
+0.6%
Q2 2023$539,799
-17.1%
50,733
-18.0%
0.31%
-10.1%
Q1 2023$651,125
-15.1%
61,8940.0%0.35%
-1.4%
Q4 2022$766,867
+20.6%
61,894
+0.8%
0.35%
+7.0%
Q3 2022$636,000
-10.2%
61,4160.0%0.33%
-4.3%
Q2 2022$708,000
-11.9%
61,416
-3.9%
0.34%
+4.9%
Q1 2022$804,000
+3.9%
63,906
-3.7%
0.33%
+5.8%
Q4 2021$774,000
-10.2%
66,366
+0.5%
0.31%
-19.6%
Q3 2021$862,000
+1.5%
66,008
+0.0%
0.39%
+1.0%
Q2 2021$849,000
+15.0%
65,9770.0%0.38%
+41.9%
Q1 2021$738,000
-1.7%
65,9770.0%0.27%
-10.9%
Q4 2020$751,00065,9770.30%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,855,515$43,661,00013.90%
BLUE JAY CAPITAL MANAGEMENT, LLC 772,369$11,810,0007.13%
Rubric Capital Management LP 1,275,000$19,495,0006.70%
SECTOR GAMMA AS 1,972,678$30,162,0005.68%
BRIDGER MANAGEMENT, LLC 1,879,313$28,735,0002.00%
Asymmetry Capital Management, L.P. 57,363$877,0001.63%
Orbimed Advisors 7,241,300$110,719,0001.41%
Broderick Brian C 144,476$2,209,0000.96%
Granahan Investment Management 1,408,000$21,528,0000.74%
Spark Investment Management LLC 499,200$7,632,0000.63%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders